These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 14557215

  • 1. Communitywide trends in the use and outcomes associated with beta-blockers in patients with acute myocardial infarction: the Worcester Heart Attack Study.
    Silvet H, Spencer F, Yarzebski J, Lessard D, Gore JM, Goldberg RJ.
    Arch Intern Med; 2003 Oct 13; 163(18):2175-83. PubMed ID: 14557215
    [Abstract] [Full Text] [Related]

  • 2. Trends and outcomes associated with angiotensin-converting enzyme inhibitors.
    Doubeni C, Bigelow C, Lessard D, Spencer F, Yarzebski J, Gore J, Gurwitz J, Goldberg R.
    Am J Med; 2006 Jul 13; 119(7):616.e9-16. PubMed ID: 16828635
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ.
    Am J Cardiol; 2008 Dec 01; 102(11):1427-32. PubMed ID: 19026290
    [Abstract] [Full Text] [Related]

  • 6. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study.
    Chandra H, Yarzebski J, Goldberg RJ, Savageau J, Singleton C, Gurwitz JH, Gore JM.
    Arch Intern Med; 1997 Apr 14; 157(7):741-6. PubMed ID: 9125005
    [Abstract] [Full Text] [Related]

  • 7. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW, Madhavan SS, Amonkar MM.
    Clin Ther; 2005 May 14; 27(5):630-45. PubMed ID: 15978313
    [Abstract] [Full Text] [Related]

  • 8. Changes over time in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction: perspectives from the Worcester Heart Attack Study.
    Thompson CA, Yarzebski J, Goldberg RJ, Lessard D, Gore JM, Dalen JE.
    Am Heart J; 2000 Jun 14; 139(6):1014-21. PubMed ID: 10827382
    [Abstract] [Full Text] [Related]

  • 9. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD, Roe MT, Mulgund J, Hoekstra JW, Santos R, Pollack CV, Ohman EM, Gibler WB, Peterson ED.
    Am J Med; 2007 Aug 14; 120(8):685-92. PubMed ID: 17679127
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gender differences in the treatment of patients with acute myocardial infarction. A multihospital, community-based perspective.
    Pagley PR, Yarzebski J, Goldberg R, Chen Z, Chiriboga D, Dalen P, Gurwitz J, Alpert JS, Gore JM.
    Arch Intern Med; 1993 Mar 08; 153(5):625-9. PubMed ID: 8439225
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

  • 17. Health insurance coverage and outcome following acute myocardial infarction. A community-wide perspective.
    Kreindel S, Rosetti R, Goldberg R, Savageau J, Yarzebski J, Gore J, Russo A, Bigelow C.
    Arch Intern Med; 1997 Apr 14; 157(7):758-62. PubMed ID: 9125007
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.
    Heller DA, Ahern FM, Kozak M.
    Am Heart J; 2000 Oct 14; 140(4):663-71. PubMed ID: 11011343
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.